S'abonner

Long-term health outcomes of children born to mothers with hyperemesis gravidarum: a systematic review and meta-analysis - 23/08/22

Doi : 10.1016/j.ajog.2022.03.052 
Kelly Nijsten, MD a, b, , Larissa A.W. Jansen, MD a, c, Jacqueline Limpens, PhD d, Martijn J.J. Finken, MD, PhD e, Marjette H. Koot, MD, PhD a, Iris J. Grooten, MD, PhD a, Tessa J. Roseboom, PhD a, b, Rebecca C. Painter, MD, PhD a
a Department of Obstetrics and Gynecology, Amsterdam Reproduction & Development, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands 
b Department of Epidemiology and Data Science, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands 
c Department of Obstetrics and Gynecology, Amphia Hospital, Breda, the Netherlands 
d Medical Library, Research Support, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands 
e Department of Paediatric Endocrinology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands 

Corresponding author: Kelly Nijsten, MD.

Abstract

Objective

Hyperemesis gravidarum is characterized by severe nausea and vomiting in pregnancy, frequently resulting in severe maternal nutritional deficiency. Maternal undernutrition is associated with adverse offspring health outcomes. Whether hyperemesis gravidarum permanently affects offspring health remains unclear. This review aimed to evaluate the effects of maternal hyperemesis gravidarum on offspring health.

Data Sources

MEDLINE and Embase were searched from inception to September 6, 2021.

Study Eligibility Criteria

Studies reporting on health at any age beyond the perinatal period of children born to mothers with hyperemesis gravidarum were included.

Methods

Two reviewers independently selected studies and extracted data. The Newcastle-Ottawa Quality Assessment Scale was used to assess risk of bias. We conducted a narrative synthesis and meta-analysis where possible. In meta-analyses with high heterogeneity (I2>75%), we did not provide a pooled odds ratio.

Results

Nineteen studies were included in this systematic review (n=1,814,785 offspring). Meta-analysis (n=619, 2 studies: 1 among adolescents and 1 among adults) showed that hyperemesis gravidarum was associated with anxiety disorder (odds ratio, 1.74; 95% confidence interval, 1.04–2.91; I2, 0%) and sleep problems in offspring (odds ratio, 2.94; 95% confidence interval, 1.25–6.93; I2, 0%). Hyperemesis gravidarum was associated with testicular cancer in male offspring aged up to 40 years on meta-analysis (5 studies, n=20,930 offspring), although heterogeneity was observed on the basis of a wide 95% prediction interval (odds ratio, 1.60; 95% confidence interval, 1.07–2.39; I2, 0%; 95% prediction interval, 0.83–3.08). All 6 studies reporting on attention deficit (hyperactivity) disorder and autism spectrum disorder reported an increase among children of mothers with hyperemesis gravidarum in comparison with children of unaffected mothers. Meta-analysis showed high heterogeneity, precluding us from reporting a pooled odds ratio. Most studies reporting on cognitive and motor problems found an increase among hyperemesis gravidarum-exposed children. One study investigated brain structure and found smaller cortical volumes and areas among children from hyperemesis gravidarum-affected pregnancies than among those from unaffected pregnancies. Studies evaluating anthropometry and cardiometabolic disease risk of hyperemesis gravidarum-exposed children had inconsistent findings.

Conclusion

Our systematic review showed that maternal hyperemesis gravidarum is associated with small increases in adverse health outcomes among children, including neurodevelopmental disorders, mental health disorders, and possibly testicular cancer, although evidence is based on few studies of low quality.

Le texte complet de cet article est disponible en PDF.

Key words : autism spectrum disorder, cardiometabolic risk factors, dyssomnias, hyperemesis gravidarum, long-term effects, meta-analysis, neurodevelopmental disorders, systematic review, testicular neoplasms


Plan


 The authors report no conflict of interest.
 This systematic review was funded by the Amsterdam Reproduction & Development (AR&D) research institute (grant number 23346) and the Dutch Heart Foundation (grant number 2013T085).


© 2022  The Author(s). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 227 - N° 3

P. 414 - septembre 2022 Retour au numéro
Article précédent Article précédent
  • Androgens and diminished ovarian reserve: the long road from basic science to clinical implementation. A comprehensive and systematic review with meta-analysis
  • Ana Raquel Neves, Pedro Montoya-Botero, Nikolaos P. Polyzos
| Article suivant Article suivant
  • Fetal reduction of triplet pregnancies to twins vs singletons: a meta-analysis of survival and pregnancy outcome
  • Kamran Hessami, Mark I. Evans, Ahmed A. Nassr, Jimmy Espinoza, Roopali V. Donepudi, Magdalena Sanz Cortes, Eyal Krispin, Shayan Mostafaei, Michael A. Belfort, Alireza A. Shamshirsaz

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.